Patient data
| Patient no. . | Sex . | Type of transplantation . | Age at transplantation, y . | Time of PTLD onset* . | Histology . |
|---|---|---|---|---|---|
| 1 | Male | Renal | 30 | Late | Polymorphic |
| 2 | Male | Lung | 24 | Early | Polymorphic |
| 3 | Female | Heart | 38 | Late | Polymorphic |
| 4 | Male | Heart | 36 | Early | DLBCL |
| 5 | Male | Heart | 50 | Late | Polymorphic |
| 6 | Female | Heart | 34 | Late | DLBCL |
| 7 | Male | Heart | 0 | Early | B-cell unclassifiable |
| 8 | Male | Renal | 51 | Late | DLBCL |
| 9 | Male | Renal | 8 | Early | Plasmacytic hyperplasia |
| 10 | Female | Renal | 34 | Early | B-cell unclassifiable |
| 11 | Female | Lung | 24 | Early | B-cell unclassifiable |
| 12 | Male | Renal | 20 | Early | B-cell unclassifiable |
| 13 | Male | Renal | 40 | Late | DLBCL |
| 14 | Male | Renal | 33 | Early | DLBCL |
| Patient no. . | Sex . | Type of transplantation . | Age at transplantation, y . | Time of PTLD onset* . | Histology . |
|---|---|---|---|---|---|
| 1 | Male | Renal | 30 | Late | Polymorphic |
| 2 | Male | Lung | 24 | Early | Polymorphic |
| 3 | Female | Heart | 38 | Late | Polymorphic |
| 4 | Male | Heart | 36 | Early | DLBCL |
| 5 | Male | Heart | 50 | Late | Polymorphic |
| 6 | Female | Heart | 34 | Late | DLBCL |
| 7 | Male | Heart | 0 | Early | B-cell unclassifiable |
| 8 | Male | Renal | 51 | Late | DLBCL |
| 9 | Male | Renal | 8 | Early | Plasmacytic hyperplasia |
| 10 | Female | Renal | 34 | Early | B-cell unclassifiable |
| 11 | Female | Lung | 24 | Early | B-cell unclassifiable |
| 12 | Male | Renal | 20 | Early | B-cell unclassifiable |
| 13 | Male | Renal | 40 | Late | DLBCL |
| 14 | Male | Renal | 33 | Early | DLBCL |
PTLD indicates post-transplantation lymphoproliferative disorder; and DLBCL, diffuse large B-cell lymphoma.
Time of onset defined as late if greater than 1 year after transplantation.